Non-genetic risk factors and predicting efficacy for docetaxel-drug-induced liver injury among metastatic breast cancer patients-Reference-Cited by-同舟云学术

Non-genetic risk factors and predicting efficacy for docetaxel-drug-induced liver injury among metastatic breast cancer patients

Published:2012-07-23 Issue:8 Volume:27 Page:1348-1352
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:

Author:

Wang Zheng,Liang Xu,Yu Jing,Zheng Xiaohui,Zhu Yulin,Yan Ying,Dong Ningning,Di Lijun,Song Guohong,Zhou Xinna,Wang Xiaoli,Yang Huabing,Ren Jun,Lyerly Herbert Kim

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2012.07131.x/fullpdf

Reference25 articles.

1. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function;Ozer;Nat. Biotechnol.,2010

2. Drug-induced liver injury: insights from genetic studies;Andrade;Pharmacogenomics,2009

3. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex;Lucena;Hepatology,2009

4. Risk factors for idiosyncratic drug-induced liver injury;Chalasani;Gastroenterology,2010

5. Epidemiology of idiosyncratic drug-induced liver injury;Bell;Semin. Liver Dis.,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Netrin-1 decorated nanoparticles combined with chemotherapy for the treatment of triple-negative breast cancer;Biomaterials Advances;2024-07

2. Liver Pathology Related to Onco-Therapeutic Agents;Surgical Pathology Clinics;2023-09

3. Synergistic Antitumor Activity of Gramicidin/Lipophilic Bismuth Nanoparticles (BisBAL NPs) on Human Cervical Tumor Cells;Frontiers in Nanotechnology;2021-04-12

4. High Serum Estradiol Reduces Acute Hepatotoxicity Risk Induced by Epirubicin Plus Cyclophosphamide Chemotherapy in Premenopausal Women with Breast Cancer;Frontiers in Pharmacology;2021-01-27

5. Clinical and genetic risk factors for the prediction of hepatotoxicity induced by a docetaxel, epirubicin and cyclophosphamide regimen in breast cancer patients;Pharmacogenomics;2021-01